Tyrosine hydroxylase of catecholamine neurons catalyzes the synthesis of 3,4-dihydroxphenylalanine (DOPA), which is subsequently metabolized to dopamine by DOPA de carboxylase (DDC), However, DOPA is not committed to de carboxylation in vivo because export of DOPA from brain and metabolism of DOPA other than decarboxylation are possible, To estimate the relative magnitudes of the several fates of DOPA, the kinetics of the uptake and metabolism of L CHJtyrosine ([3HJTyr, intravenous infusion) was measured in brain of rats pretreated with NSD 1015, an inhibitor of DDC, Some rats were pretreated with haloperidol before the blockade of DDC, The [3H1Tyr was incorporated into brain protein at a rate constant of 0,03 min-t, The relative tyrosine hydroxylase
Tyrosine hydroxylase (TH, EC 1. 14. 13 .2) is thought to be the rate-limiting step in dopamine (DA) synthesis, but rate-limitation requires that the product be committed to a single pathway (i.e., that alternative fates be unavail able). In theory, the TH product 3,4-dihydroxphenylala nine (DOPA) is not wholly committed to decarboxyl ation by DOPA decarboxylase (DDC) because at least two additional pathways are available to this amino acid in living brain, including methylation in situ by catechol O-methyltransferase (COMT), and export from the cells and interstitium by the facilitated diffusion transporter of large neutral amino acids. Spillover of DOPA into ve-activity in striatum was 0,005 min-I at 30 minutes after NSD 1015, 0,011 min-I 3 hours later, and 0,020 min-I after halo peridol treatment The rate constant for the clearance of DOPA from brain (0,06 min-I) and earlier estimates of the rate con stant of DDC activity in striatum (0,26 min-I) together predict that 80% of DOPA formed in normal rat striatum normally is available for dopamine synthesis, It follows that modulation of DDC activity can influence the rate of DA synthesis by affect ing the relative magnitude of the several fates of DOPA in living brain, Key Words: DOPA-DOPA decarboxylase Dopamine-Tyrosine-Tyrosine hydroxylase-Metabolism NSD 1015-Striatum-Haloperidol-Protein synthesis. nous blood has been detected from human brain (Eisen hofer et aI., 1989; Gjedde et aI., 1995) and human sym pathetic nerves (Eldrup et aI., 1994) . The existence of alternative routes of DOPA disposition and metabolism requires a revision of the dogma of exclusive rate control of DA synthesis by TH activity. Equally, the noncom mitted nature of DOPA synthesis limits the usefulness of NSD lOIS blockade of DDC to determine the rate of DOPA, and hence DA synthesis (Carlsson et aI., 1972) . To test the hypothesis of multiple DOPA pathways, we established a kinetic model of eH]tyrosine (eH]Tyr) metabolism in brain of living rats pretreated with NSD lOIS.
Labeled catecholamines are formed in rodent brain after peripheral injection of eH]Tyr (Zigmond and Wurt man, 1970) . We have used a multicompartmental model to describe the uptake and metabolism in rat brain of the DDC tracers 6-e 8 p]f]uoro-DOPA (Cumming et aI., 1994a) and eH]DOPA (Cumming et aI., 1995 , Cum ming et aI., 1997 . As an extension of this model, we now describe the pathway for eH]Tyr metabolism in kinetic terms (Pig. 1). The tracer in arterial plasma is reversibly transferred into brain by facilitated diffusion (K/Y" mL g-I min-I , k2 T yr, min-I ). We assume that eH]Tyr and 492 P. CUMMING ET AL. other amino acids in brain occupy a single homogeneous compartment, also containing the enzymes TH and DDC. This assumption is valid given that eH]Tyr, eH]DOP A, and other large neutral amino acids are freely diffusible, such that concentration gradients between brain water and specific cellular compartments containing enzyme activities cannot occur. Thus, eH]Tyr in brain is hydrox ylated with a rate constant k T H (min-I ) to yield eH]DOPA, or is incorporated into brain protein by a series of steps with a lumped rate constant kb p T yr (min-I ).
The net clearance rate constant of eH]Tyr from brain (k T yr) is thus equal to the sum (k T yr + k
Similarly, the rate constant for the net clearance of [3H]DOPA from brain (kclDOPA) is the sum of the rate constants for facilitated diffusion from brain (k2 D OPA, min-I), O-methylation in situ by COMT (ks D OPA, min-I), and decarboxylation by DDC (k 3 D OPA, min-I). The current model of cerebral eH]Tyr metabolism iden tifies a series of processes, all of which can be measured during radiotracer experiments.
METHODS
Male Wistar rats (250 to 300 g, Charles River, Quebec, Canada) received heparin-containing catheters to the right femoral artery and vein while anesthetized with halothane (2%, Ayerst). After surgery, rats received NSD 1015 (3hydroxybenzylhydrazine-2HCl, ISO mg/kg intraperitoneally, Research Biochemicals Natick, MA, U.S.A.) and were placed J Cereh Blood Flow Metab, Vol. 18, No.5, 1998 in plaster body casts for either 30 minutes (n = 12) or 3.5 hours (n = 12). Other rats (n = 9) received haloperidol (3 x 2.5 mg/kg intraperitoneally, Research Biochemicals) at 8-hour in tervals before surgery, followed by treatment with NSD lOIS during 30 minutes. At the end of the postoperative period, eHjTyr 50 Cilmmol, New England Nuclear Boston, MA, U.S.A.) was injected as an intravenous infusion during 1 minute (500 ILCi/kg) in a total volume of 600 fJ.L saline. After initiation of tracer injection, arterial blood samples were collected every 30 seconds for the first 2 minutes and at longer intervals thereafter.
After rapid centrifugation of whole blood, plasma was re moved and mixed with an equal volume of perchloric acid (0.5 moUL), placed on ice for IS minutes, and recentrifuged (14,000 g x 10 min). Portions of the extracts (50 ILL) corresponding to 25 ILL of raw plasma were transferred to scintillation vials, and to each vial 10 mL scintillation counting fluid (BCS, Amer sham, Oakville, Ontario, Canada) was added. Total perchloric acid-soluble radioactivity was counted by scintillation spectros copy with windows set at 10 to 250 keV and calculated as disintegrations per minute (dpm) per microliter of original plasma.
For each experimental condition, rats (n = 1 to 3) were killed by decapitation at 2, 5, 10, 15, 30, or 45 minutes of tracer circulation. Brains were dissected rapidly on ice into five re gions: striatum, olfactory tubercle, neocortex, hippocampus, and hypothalamus. Each brain sample was weighed, sonicated in 10 volumes of perchloric acid (0.1 moUL), placed on ice for 10 minutes, and centrifuged (14,000 g x 10 minutes). Total perchloric acid-soluble radioactivity in I OO-fJ.L portions of the extracts, corresponding to 10 mg of brain tissue, was measured by scintillation spectroscopy and calculated as disintegrations per minute per milligram of tissue. Each protein pellet was dissolved overnight in 1 mL of organic base (NCS-I1, Amer sham) and transferred into plastic vials containing 200 fJ.L gla cial acetic acid and 10 mL scintillation fluid. Radioactivity concentrations in the perchloric acid-insoluble pellets were then measured and calculated as disintegrations per minute per milligram of tissue.
Plasma and brain extracts were fractionated by reversed phase HPLC (Alltech Alltima, 4.6 x ISO mm Deerfield, IL, U.S.A.). The mobile phase, consisting only of 50 mmollL so dium phosphate (pH 3.7) and 10% methanol, was delivered at 1.2 mLimin. Retention volumes of pure standards (Sigma, SI. Louis, MO, U.S.A.) were determined by ultraviolet absorption at 270 nm: Vo = 1.7 mL, DOPA = 4.3 mL, DA = 5.4 mL, Tyr = 6.5 mL, and OMe-DOPA = l3.7 mL. Fractions of the eluent (20 x 0.4 minutes followed by 8 x 1 minute) were collected, and the radioactivity in each fraction measured by scintillation spectroscopy. The area of each radiochemical peak was calculated as a percentage of the total radioactivity recov ered in the HPLC radiochromatogram. Recoveries of total ra dioactivity were greater than 90%. For each identified radio chemical species, the product of its percentage abundance in the radiochromatogram and the total soluble radioactivity per microliter of unfractionated plasma or milligram of brain was used to calculated the tracer metabolite concentrations in plasma (dpm/ILL) or brain tissue (dpm/mg). The concentration of endogenous Tyr in some plasma extracts was determined by HPLC with on-line ultraviolet absorption detection (Waters Model 480) at 270 nm.
The normalized arterial plasma integrals for eHJTyr (O, minutes) , defined as the integrated activity divided by c�yr (T), the arterial concentration at the end of integration (Gjedde 1981 (Gjedde , 1982 Patlak et aI., 1983) were calculated and plotted as 
where K) Tyr is the unidirectional blood-brain clearance of eH1Tyr, and kelTyr the net rate constant of loss of eH1Tyr from brain by all processes identified in Fig caused by catalytic exchange of the tritium in the me t a position. Tritiated water mixes rapidly with body water: only traces of [,H1H20 were present in radiochromatograms from plasma and brain extracts. Consequently, the value of MtTyr in equation (3) is corrected for the 50% decline in specific activity of eH1DOPA with respect to that of the precursor r3HJTyr.
In brain, the ratio of perchlorate-precipitated radioactivity to
where khpTyr is the lumped rate constant for incorporation of eH1Tyr into a perchlorate-insoluble pool (brain protein), (>1b the normalized integral of [:lH1Tyr in brain calculated from the integration of equation (2), and Ro the initial fraction of [3H1Tyr reversibly bound as aminoacyl-tRNA, before the "ir reversible" incorporation into brain protein.
Nonlinear regressions were completed with the Matlab soft ware (Mathworks, Inc., Cambridge, MA, U.S.A.). Best esti mates are reported ±95% confidence intervals of the regression estimates, or mean ± SE of repeated measures. Significance of treatment effects was tested using the z test, or, in the case of repeated measures, the Student's t-test.
RESULTS
The only radiochemical peaks in plasma extracts were eH]Tyr, and a peak eluting with the solvent front. This peak, presumably eH]H20 derived from spontaneous or catalytic exchange of ring-tritium with protons from plasma water, initially accounted for less than 5% of total recovered radioactivity in plasma extracts, but comprised up to 10% of total radioactivity at 45 minutes of tracer circulation. Neither eH]DOPA nor OMe-l3H]DOPA were detected in plasma extracts. The relation between circulation time and the normalized arterial integral for eH]Tyr (e) in 12 rats treated with NSD 10 15 30 minutes before tracer injection is illustrated in Fig. 2A . The popu- 2B . Figure 3 shows the scaled concentrations of eH]Tyr in striatum of rats treated at 30 minutes (Fig. 3A ) and 3.5 hours (Fig. 3B ) before tracer injection, or after NSD 1015 plus haloperidol (Fig. 3C) . The smooth curves in- The unidirectional blood-brain clearance (KiY') and the total loss rate constant (k�Y') for ['HJTyr (500 flCilkg, intravenously) in five brain regions of groups of (n) rats at 30 minutes (n = 12) or 3.5 h (n = 12) after NSD 1015 (150 mg/kg, intraperitoneally), and at 30 minutes after NSD lOIS in rats treated with haloperidol at 8-hour intervals (3 x 2.5 mg/kg, intraperitoneal1y, n = 9). Parameters (± 95% confidence inter vals) were calculated by nonlinear fitting of a one-compartment model to the scaled ['HJTyr concentrations measured in brain and the com mon arterial input function during 45 minutes. Tyrosine concentrations in brain are calculated from the product of vpr (Kiyr /k�yr) and the plasma Tyr concentrations measured for each population. hal, haloper idoL Significance of differences from 0.5 h group: *p < 0.05; tP < 0.00 I; :j:not significant.
dicate the fitting of equation (2) to the data points. The mean (±SD) unidirectional blood-brain clearances of eH]Tyr in five brain regions were 0.064 ± 0.009 mL g-l min-1 at 30 minutes after NSD 1015,0.053 ± 0.005 mL g-l min-1 3 hours later, and 0.058 ± 0.010 mL g-l min-I after haloperidol ( Table 1) . The magnitude of K1 T yr was significantly lower in three of five brain regions (stria tum, olfactory tubercle, and hypothalamus) of rats treated with NSD 1015 for 3.5 hours, and in one of five brain regions (hippocampus) of haloperidol-treated rats. The mean value (±SD) of kel T yr in five brain regions was 0.149 ± 0.013 min-I at 30 minutes and 3.5 hours after NSD 1015, but was reduced to 0.109 ± 0.016 min-I after haloperidol (P < 0.01, Student's t-test [3HlTyr injection (500 j.lCi/kg intravenously) at 30 minutes (A) or 3.5 hours (8) after treatment with NSD 1015 (150 mg/kg intra peritoneally), and after haloperidol plus NSD 1015 (C). Each point is the mean of two or three separate determinations scaled to a common arterial curve. The smooth curves illustrate the fitting of a one-compartment model to the scaled [3H]DOPA con centrations measured in brain and the calculated [3H]Tyr input function in brain. eHlDOP A measured in striatum of rats with tracer in jections at 30 minutes (Fig. 4A ) and 3.5 hours after NSD 1015 (Fig. 4B) , or after haloperidol plus NSD 1015 (Fig.  4C) . The smooth curves indicate the fitting of equation
(3) to the data. The rate constants for the relative TH activity ranged from 0.0001 min-I in cortex to 0.0048 min-l in striatum at 30 minutes after NSD 1015 (Table   2) . Three hours later, the magnitude of k T H had increased nearly twofold in striatum and other brain regions, ex cepting the hypothalamus. Haloperidol administration re sulted in a fourfold stimulation of k T H in striatum.
The accumulation of eHl-Iabeled protein in rat stria tum as a function of the normalized integrals of free brain [3HlTyr 30 minutes or 3.5 hours after NSD 1015, and after NSD 10 15 together with haloperidol pretreatment, are illustrated in Fig. 5 . The average initial bound frac tion Ro of eHlTyr in five brain regions (±SD) was 0.19 ± 0.04 in rats treated only with NSD 1015 either 30 minutes or 3.5 hours previously, but increased to 0.27 ± 0.02 in the haloperidol-treated group ( Table 3 , P < 0.005, Student's t-test). The mean rate constants (±SD) for in corporation of eHlTyr into protein in five brain regions was 0.030 ± 0.004 min-I (±SD) in rats treated only with NSD 1015 either 30 minutes of 3.5 hours previously, but was significantly lower (0.016 ± 0.001 min-I) in the group with haloperidol pretreatment. Rates of incorpo ration of [3HlTyr into brain protein are calculated as the product of kb/yr (Table 3 ) and the calculated brain Tyr concentrations ( Table I) . In striatum of all three treat ment groups, the rates so calculated are close to 750 pmol Tyr per gram of brain tissue per minute.
Subtracting from ke l T yr ( The relative TH activity ( kTH ) and the net rate constant of the clear ance of r3H]DOPA from brain ( k �OPA ) measured in five brain regions of groups of (n) rats receiving [3H]Tyr (500 J..C Ci/kg, intravenously) at 30 minutes (n = 12) or 3.5 h (n = 12) after NSD 1015 (150 mglkg, intraperitoneally), or after acute haloperidol (hal) (3x2.5 mglkg, intra peritoneally, n = 9) plus NSD 1015 (150 mg/kg, intraperitoneally). Parameters (± 95% confidence intervals) were calculated from the tit ting of a one-compartment model to the scaled concentrations of [,H] Tyr and [,H] DOPA measured in brain over 45 minutes. DOPA syn thesis is calculated from the product of kTH and the calculated brain Tyr concentration (Table I) . NO, not detected, as the nonlinear regression failed to converge because of low signal. Significance of difference from 0.5 h group: *p < 0.001; tnot significant. 
DISCUSSION
The unidirectional blood-brain clearances of eH]Tyr in the present study ( aI., 1983). The present experiments with the neuroleptic treated rats were carried out 1 month after the other groups, suggesting that the elevated plasma Tyr concen trations may have resulted from in-group variability rather than drug treatment.
In the present study, the predominant pathway for eH]Tyr in rat brain (3% per minute) was protein syn thesis. Likewise, L-[2-1 8 p]fluorotyrosine was substan tially trapped as protein in mouse brain (Coenen et aI., 1989) . The changes in cerebral eH]Tyr disposition in the haloperidol-treated group were consistent with the el evated plasma and cerebral Tyr concentrations, such that the rate of protein synthesis, proportional to the product of kb p T y r and the cerebral concentration of Tyr, was un affected by haloperidol. We suggest that the rate constant for brain-blood clearance of eH]Tyr was lower in halo peridol treated rats because of the sum of two factors: the fraction of eH]Tyr (but not the absolute amount of Tyr) entering into protein synthesis was lower, and the frac tion entering into catecholamine synthesis was greater.
By this argument, we calculate that, were eH]Tyr not metabolized in brain, v?y r would rise from 0.42 mL g-l ( Table I) to nearly 0.55 mL g-I (V e T y r ) , closer to the Hypo-0.5 h 0.029 ± 0.001 0.21 ± 0.05 841 thalamus 3.5 h 0.031 ± 0.002:j: 0.20 ± 0.08:j: 806 hal 0.016 ± 0.001 t 0.28 ± 0.03* 1008
The rate constants calculated for the incorporation of [3HJTyr (500 [LCi/kg, intraperitoneally) into brain protein (k��C) and the precursor volumes of [3H] Tyr for rat brain protein synthesis (Ra) in five brain regions of groups of (n) rats receiving ['HjTyr (500 [LCilkg, intrave nously) at 30 minutes (n = 12) or 3.5 h (n = 12) after NSD lOIS (150 mg/kg, intraperitoneally), and after acute haloperidol (hal) (3 x 2.5 mg/kg, intraperitoneally, n = 9). The rate of incorporation of Tyr into protein (pmol Tyr per gram of brain tissue per minute) is calculated as the product of k��c and the estimated free Tyr concentration (Table I) . Each parameter, calculated by linear regression of the measured la belled protein fractions plotted as a function of the normalized integral for free ['HjTyr in brain, is reported ± 95% confidence intervals. Sig nificance of differences from 0.5 h group: *p < 0.05; tP < 0.001; :j:not significant.
r ' H]DOPA AND DOPAMINE SYNTHESIS 497 partition volume reported for the inert Tyr derivative [ 1 4C]AMPT (0.7 mL g-I, Cumming et aI., 1994b) , which is not a substrate for protein synthesis. Thus, protein synthesis, and, to a lesser extent, TH activity, can influ ence the precursor concentration for catecholamine syn thesis in brain.
We have previously measured the relative DDC activ ity in the rat striatum with respect to 6-esF]fluoro DOPA (0.17 min-I , Cumming et aI., 1994a) and [3H]DOPA (0.26 min-I, 0.20 min-I, Cumming et aI., 1997) . In the present study, blockade of DDC was complete at 30 minutes after NSD 1015, although traces of [3H]DA were formed in striatum at 3.5 hours after DDC inhibition (not shown). Traces of OMe-eH]DOP A were detected in striatum and olfactory tubercle in the current study, but these concentrations were variable and therefore uninformative about the magnitude of ks D OPA, the COMT activity in brain.
In the present study, the activity of TH was stimulated in striatum, olfactory tubercle, cortex, and hippocampus, but not in hypothalamus ( Table 2 ) after prolonged block ade of DDC and after subchronic haloperidol treatment.
The neuroleptic-induced stimulation of TH in rat stria tum is related to an increased affinity of the enzyme for reduced pteridine, the limiting substrate (Zivkovic et a!., 1974, Levine et aI., 1979, Pradhan et aI., 198 1) , which is mediated by DA autoreceptors (Strait and Kuczenski, 1986 ) through regulation of adenylate cyclase activity (Goldstein et aI., 1976, El Mestikawy and Hamon, 1986) .
The insensitivity of hypothalamic TH activity to neuro leptics, which has been noted previously (Zivkovic et aI., 1974) , may reflect the location of TH in hypothalamus within noradrenergic fibers, or other compartments lack ing DA autoreceptors.
The present finding of increased magnitude of k TH in the rat basal ganglia after prolonged DDC inhibition may reflect feedback activation of TH in response to DA depletion. Synthesis of DA in the rat medial prefrontal cortex is impaired in several experimental models that reduce brain Tyr levels, but Tyr supplements only en hance DA synthesis when the neurons are stimulated (Tam and Roth, 1997 (5)
Using values in Tables 1 and 2, we can calculate the DOPA concentration in striatum to be 4 ILmollL at 30 minutes and 3 hours after NSD 10 15 and 16 ILmollL after haloperidol. This finding is comparable with the three fold increase in DOPA efflux reported after haloperidol in microdialysis studies (Westerink et aI., 1990) . After haloperidol, the relative TH activity in striatum ( Table 2) increased to the same magnitude as the rate constant for incorporation of Tyr into brain protein (Table 3) , sug gesting that TH activity in a stimulated condition could be detected in human brain by positron emission tomog raphy with labeled Tyr.
The mean (±SE) estimate of the total loss rate constant
[3H]DOPA from five brain regions (kc l DOPA) at 30 min utes after NSD 1015 (0.06 ± 0.02 min-I) is nearly iden tical to an earlier estimate (Cumming et aI., 1995) . Cumming et aI., 1995; 0.20 min-I , Cumming et aI., 1997) suggest that 75% to 90% of endogenously formed DOPA in rat striatum normally is committed to DA syn thesis in these structures. The current results obtained in rat are not in complete agreement with our estimate based on positron emission tomography studies with FDOPA that 50% of DOPA is exported from normal human caudate/putamen (Gjedde et aI., 1993) . This dis crepancy may be attributed to the lower magnitude of k3 D OPA obtained in human positron emission tomogra phy studies with FDOP A than in rat studies with labeled DOPA. From earlier estimates of k3 D OPA (Cumming et aI., 1995) in cortex and hippocampus (0.02 min-I ), and hypothalamus (0.04 min-i ), we calculate that more than half of DOPA formed in these tissues is normally me tabolized by COMT or exported from rat brain, rather than decarboxylated in situ.
The present study predicts that DOPA concentrations in striatum should increase from 0.4 to 4 f,Lmol/L after acute treatment with NSD 1015, a prediction contrasting with the 100-fold increases commonly measured in stria tal microdialysates (Westerink et aI., 1990; Nakemura et aI., 1992; Hashiguti et aI., 1993; Tammela et aI., 1993) . This discrepancy suggests that additional factors such as compartmentalization in vivo or postmortem effects may result in systematic underestimation of basal DOPA in brain tissue or the basal efflux of DOPA in microdialy sates. The plateau in cerebral DOPA concentration com monly observed several hours after DDC blockade may well reflect TH activity at the new steady state (equation [5] ), but we currently find that a twofold activation of TH in the basal ganglia has occurred, possibly is a conse quence of depletion of DA. Thus, steady-state DOPA concentrations attained several hours after NSD 1015 occur as a function of perturbed TH activity.
In conclusion, a substantial fraction of DOPA formed within living brain is not used as precursor for catechol amine synthesis but is exported from brain. It follows that the activity of DDC in vivo determines the relative magnitude of the several possible fates of DOPA. The elevated DDC activity from rodent striatum measured ex vivo after neuroleptic treatment (Zhu et aI., 1992; Had jiconstantinou et aI., 1993) and in striatum of living rats treated with flupenthixol (Cumming et aI., 1997) , and the decreased magnitude of DDC activity in rat striatum af ter acute pargyline treatment (Cumming et aI., 1995) suggest that the fraction of endogenous DOPA trapped as catecholamines can be modulated pharmacologically, probably via activation of autoreceptors on DA termi nals.
